![Holger Liepmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger Liepmann
Presidente presso
F3 Platform Biologics, Inc.
Profilo
Holger A. Liepmann is currently the Chairman of F3 Platform Biologics, Inc. and a Director at PanTheryx, Inc., Desert Research Institute Foundation, and SmartTots.
He previously held positions as Chairman at Abbott GmbH (Germany), Director at Verenium Corp., Enzymotec Ltd., and Altan Pharma Ltd., and Executive Vice President at Abbott Laboratories and Pharmaceutical Products.
He was also a Senior Vice President at Abbott International LLC and a Marketing Manager-Europe at Cutter Laboratories, Inc. Liepmann received his undergraduate degree from Dartmouth College and his MBA from Stanford University.
Posizioni attive di Holger Liepmann
| Società | Posizione | Inizio |
|---|---|---|
Desert Research Institute Foundation
 Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Supports environmental science research to maximize DRI's impact on improving people's lives | Direttore/Membro del Consiglio | - |
SmartTots | Direttore/Membro del Consiglio | - |
PanTheryx, Inc.
 PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Direttore/Membro del Consiglio | 10/04/2020 |
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Presidente | - |
Precedenti posizioni note di Holger Liepmann
| Società | Posizione | Fine |
|---|---|---|
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets injectable medications | Direttore operativo | 02/01/2021 |
| VERENIUM CORP | Direttore/Membro del Consiglio | 31/10/2013 |
Abbott International LLC | Corporate Officer/Principal | 02/01/2011 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2011 |
Pharmaceutical Products | Corporate Officer/Principal | - |
Formazione di Holger Liepmann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
94
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
PanTheryx, Inc.
PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Pharmaceutical Products | |
Desert Research Institute Foundation
Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Supports environmental science research to maximize DRI's impact on improving people's lives | Commercial Services |
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Develops, manufactures and markets lipid-based bioactive ingredients | Health Technology |
Abbott International LLC | |
Cutter Laboratories, Inc. | |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets injectable medications | Health Technology |
SmartTots | |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Health Technology |
